Texas Attorney General Sues Acetaminophen Manufacturers Concerning Autism Assertions

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of acetaminophen, alleging the companies withheld safety concerns that the medication posed to children's cognitive development.

The court filing follows four weeks after Donald Trump publicized an unverified association between consuming acetaminophen - referred to as acetaminophen - during pregnancy and autism in young ones.

The attorney general is suing J&J, which previously sold the drug, the sole analgesic recommended for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from pain and marketing drugs without regard for the risks."

Kenvue says there is no credible evidence linking Tylenol to autism.

"These companies misled for generations, deliberately risking millions to line their pockets," Paxton, a Republican, said.

The company stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the potential impact that could have on the health of American women and children."

On its website, Kenvue also said it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a verified association between taking acetaminophen and autism spectrum disorder."

Associations speaking for physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to treat discomfort and elevated temperature, which can present significant medical dangers if not addressed.

"In multiple decades of research on the utilization of paracetamol in gestation, not a single reputable study has definitively established that the use of paracetamol in any period of gestation causes brain development issues in young ones," the organization commented.

The court filing references current declarations from the former administration in asserting the medication is allegedly unsafe.

In recent weeks, Trump raised alarms from medical authorities when he instructed pregnant women to "fight like hell" not to use Tylenol when ill.

The FDA then issued a notice that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a proven link" between the drug and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had pledged in April to conduct "comprehensive study program" that would determine the origin of autism in a short period.

But experts advised that identifying a unique factor of autism - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a category of lifelong neurodivergence and disability that influences how people experience and engage with the environment, and is recognized using physician assessments.

In his legal document, the attorney general - aligned with the former president who is running for US Senate - claims the manufacturer and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the firms "eliminate any marketing or advertising" that claims acetaminophen is safe for expectant mothers.

The Texas lawsuit mirrors the grievances of a group of parents of children with autism and ADHD who sued the producers of acetaminophen in 2022.

Judicial authorities rejected the case, stating studies from the family's specialists was inconclusive.